In this video from Clinical Trials at the Summit, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses ...

The House has passed the Trump administration’s sweeping domestic agenda bill, which experts said will have massive ...

The FDA granted accelerated approval of linvoseltamab-gcpt for certain patients with multiple myeloma.Specifically, the ...

Implementing bedtime and naptime routines for newborns may improve infant and parent sleep and help families with bonding, ...

Eye care practitioners were satisfied with the performance of Xiidra in reducing the signs and symptoms of dry eye disease in ...

Long-term antihypertensive therapy was not associated with risk for cancer, cancer-related mortality or site-specific cancers ...

We recently finished a small consulting project in a suburban Paris eye clinic. Opportunities like this to evaluate and ...

An alternative delirium assessment tool may provide more equitable ICU care for Latino patients with limited English ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...

Nemluvio was well tolerated and showed sustained improvements in moderate to severe prurigo nodularis during a 2-year ...

Electra D. Paskett, PhD, MSPH, FACE, FAACR, was elected as a fellow to the American Association for Cancer Research Academy ...